Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Sponsor

Hmg Biologics S.r.l.

Italy Corso Vittorio Emanuele II 30, 20122 Milan, Italy

About the sponsor

Hmg Biologics S.r.l. is involved in clinical research focused on refractory wounds, with particular attention to conditions that do not respond adequately to standard care. Its research activity centers on chronic wound repair and the use of biologic approaches to support tissue recovery.

  • Chronic refractory wounds
  • Wound regeneration
  • Soft tissue repair

The sponsor’s therapeutic interest lies in cell-based wound treatment, especially applications intended to improve healing in difficult-to-treat lesions.

About Specializations

Hmg Biologics S.r.l. runs clinical trials in conditions such as Skin wound, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Skin wound

Not yet recruiting

Safety, tolerability and efficacy of topical human fibroblasts in patients with chronic refractory wounds (two-part study)

InvestigationalNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Human fibroblasts
  • Sponsor:Hmg Biologics S.r.l.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.